
Tesla awards CEO Musk millions of shares valued at about 29 billion dollars
The electric vehicle maker said in a regulatory filing on Monday that Mr Musk must first pay Tesla 23.34 dollars per share of restricted stock that vests, which is equal to the exercise price per share of the 2018 pay package that was awarded to the company's CEO.
In December, Delaware chancellor Kathaleen St Jude McCormick reaffirmed her earlier ruling that Tesla must revoke Mr Musk's multibillion-dollar pay package.
She found that Mr Musk engineered the landmark pay package in sham negotiations with directors who were not independent.
Elon Musk, CEO of Tesla (PA)
At the time, Ms McCormick also rejected an equally unprecedented and massive fee request by plaintiff attorneys, who argued that they were entitled to legal fees in the form of Tesla stock valued at more than five billion dollars.
The judge said the attorneys were entitled to a fee award of 345 million dollars.
The rulings came in a lawsuit filed by a Tesla stockholder who challenged Mr Musk's 2018 compensation package.
That pay package carried a potential maximum value of about 56 billion dollars, but that sum has fluctuated over the years based on Tesla's stock price.
Mr Musk appealed against the order in March. A month later Tesla said in a regulatory filing that it was creating a special committee to look at Mr Musk's compensation as CEO.
Wedbush analyst Dan Ives feels Mr Musk's stock award may alleviate some Tesla shareholder concerns.
'We believe this grant will now keep Musk as CEO of Tesla at least until 2030 and removes an overhang on the stock,' Mr Ives wrote in a client note.
'Musk remains Tesla's big asset and this comp issue has been a constant concern of shareholders once the Delaware soap opera began.'
Tesla shares have plunged 25% this year, largely due to blowback over Mr Musk's affiliation with President Donald Trump.
But Tesla also faces intensifying competition from both the big Detroit car makers, and from China.
In its most recent quarter, Tesla reported that quarterly profits plunged from 1.39 billion dollars to 409 million dollars.
Revenue also fell and the company fell short of even the lowered expectations on Wall Street.
Under pressure from shareholders last month, Tesla scheduled an annual shareholders meeting for November to comply with Texas state law.
A group of more than 20 Tesla shareholders, which have watched Tesla shares plummet, said in a letter to the company that it needed to at least provide public notice of the annual meeting.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Agriland
an hour ago
- Agriland
Moy Park fined for failing to comply with pollution prevention permit
Poultry company Moy Park has been fined a total of £4,000 for failing to comply with conditions of its pollution prevention and control permit at its facility at Larne Road, Ballymena. The company pleaded guilty to the charges at Ballymena Magistrates' Court yesterday (Wednesday, July 23). The court heard that between July 1, 2024 and July 11, 2024, officers from the Northern Ireland Environment Agency (NIEA) inspected the Co. Antrim site and observed multiple breaches of the permit contrary to Regulation 36(1)(b) of the Pollution Prevention and Control Regulations (Northern Ireland) 2013. The court was told that the offences included: Failure to handle and store animal by products within suitably leak proof covered receptacles; Failure to maintain all plant and equipment in good operating condition; Failure to store all Category 3 materials in enclosed bins; Failure to notify the chief inspector without delay of any fugitive emissions which had caused, was causing or may have caused significant pollution. The court directed that Moy Park must pay the order in full within three months of the hearing date. In a statement issued by Moy Park, the company said that "the proceedings related to historic issues over a short period in the run up to the busy July bank holiday in Northern Ireland last year". "All issues were rectified to the satisfaction of the regulator shortly after the incident dates. "In addition, the site has benefited from a continuing programme of site investment and production improvement works to eliminate the risk of reoccurrence. "As confirmed by the court, no actual pollution occurred," the company added. In October, Moy Park reported revenue of £2.03 billion for 2023, up 10.7% on the previous year (£1.83 billion). Moy Park, which is Northern Ireland's largest private sector business and one of Europe's leading poultry producers, also said that operating profits rose by 151% to £75.3 million (2022: £30 million). The company, which was acquired by US-based Pilgrim's Pride Group in 2017, said profit after tax in 2023 was recorded at £55.8 million, up from £19.8 million a year previously. 'Unrelenting focus on cost control, excellent customer relationships and a culture of constant innovation in an ever changing competitive landscape mitigated some of these challenges,' the company said.


RTÉ News
6 hours ago
- RTÉ News
US pharma firms will be 'damaged' by tariffs
Taoiseach Micheál Martin said President Donald Trump should keep in mind that US pharmaceutical firms based in Ireland will be "damaged and undermined" if he goes through with his latest sectoral tariffs threats. Mr Trump said the 15% baseline agreed in the EU-US tariff deal last month would only apply to the pharmaceutical sector for "one year, one-and-a-half years maximum". The US President also said "it's [the pharmaceutical tariff] going to go to 150%, and then it's going to go to 250% because we want pharmaceuticals made in our country," before specifically referencing companies based in China and Ireland. It follows the European Commission's spokesperson on trade Olof Gill insisting that the 15% rate is an "insurance policy". His comment comes amid a section 232 investigation into tariffs on pharmaceutical that is under way taking place in the US. The probe could result in Mr Trump, rather than the US Congress, attempting to unilaterally increase pharmaceutical tariffs above the 15% rate. He alluded to before his deal with the EU by telling reporters the pharmaceutical sector is "special". However, responding to Mr Trump's suggestion that pharmaceutical tariffs could surge far above the agreed 15% rate in the future, Mr Martin said this should not be the case. He added that Mr Trump should keep in mind that US pharmaceutical firms based in Ireland will be "damaged and undermined" if any tariff increases occur. "I've had some more recent conversations in light of the negotiations between the EU and US. "There are certain realities applying here, and the overall point I would make is that tariffs are not good for the world economy, they're not good for people, workers or consumers. "And in the context of pharmaceutical companies, the US has gained increasing share of European pharmaceutical market and indeed of Asian markets because of their presence in the markets. "The companies are global powers now, really globally strong companies, because of their presence in Europe, Ireland being one of the countries that they're present in," Mr Martin said. He added: "Ireland has added value and strength to those companies, and I would say to the [US] President he needs to factor that into the equation. "Those companies will be damaged and undermined if such policies were to bear fruit. "But we understand, and I've been in touch with the president of the commission last week and Commissioner Šefčovič, that the 15% is what's being negotiated, has been negotiated, between the US and EU." The presence of multi-national companies and international pharmaceutical firms in Ireland is a key component of the current Irish economy, directly impacting on thousands of jobs across the country.


Irish Times
6 hours ago
- Irish Times
Trump hails additional $100bn Apple investment in US
US President Donald Trump will announce an additional $100 million investment by tech giant Apple in its US manufacturing network, White House officials said on Wednesday. It comes as Apple tries to avoid US tariffs on imports that will impact the cost of iPhones and other products in the US. The announcement will be seen by the Trump administration as a big victory is his crusade to restore domestic manufacturing. But the scale of the investment will raise concerns in Irish Government circles about what it might mean for the company's commitment to its Irish manufacturing base, which employs more than 6,000 staff. The US president is hoping his threat of tariffs on imports will pressure companies to increase manufacturing inside the US, the stated aim of his America First agenda. READ MORE 'President Trump's America First economic agenda has secured trillions of dollars in investments that support American jobs and bolster American businesses,' White House spokeswoman Taylor Rogers said in a statement. 'Today's announcement with Apple is another win for our manufacturing industry that will simultaneously help reshore the production of critical components to protect America's economic and national security,' he said. In February, Apple said it planned to hire an additional 20,000 staff in the US over the next four years, as part of a $500 billion investment in the country during Trump's second term in office, a figure that is now expected to increase to $600 billion. The company made similar, smaller pledges during the Biden administration and Trump's first term, though it has not yet followed through on some of those promises. While Apple supports more than 450,000 jobs with thousands of suppliers and partners across 50 states, the president has been concerned at the company's plan to expand its manufacturing footprint in India. In May, Trump threatened Apple and other phone manufacturers with a 25% tariff on products made outside the United States. Bloomberg Intelligence analysts Anurag Rana and Andrew Girard said the latest Apple pledge of investment may 'soften the White House's ire' over Apple's heavy reliance on India for iPhone assembly. 'We anticipate Apple will focus on higher-end products, artificial intelligence labs and semiconductor engineering in the US, rather than mass-produced lower-end phones and accessories.' Mr Trump's announcement, which was reported earlier by Bloomberg, will include the creation of what the White House is calling the 'American Manufacturing Programme', which will focus on bringing more of Apple's supply chain and advanced manufacturing to the United States. The US president is hoping his threat of tariffs on imports will pressure companies to increase manufacturing inside the US, the stated aim of his America First agenda. The Apple announcement comes on the day that Mr Trump signed an executive order imposing an additional 25 per cent tariff on imports from India which, he said, was due to New Delhi's purchases of Russian oil. The order said the 25 per cent levies would be added to existing duties imposed on Indian imports in a move that will raise tensions with prime minister Narendra Modi's government. India has failed to reach a trade deal with Washington and was already facing 25 per cent tariffs on its exports to the US before Mr Trump's announcement. A 15 per cent tariff on most EU exports to the US is scheduled to come into force on Thursday. Both the European Commission and the While House had confirmed previously that the 15 per cent rate would include pharmaceuticals and semiconductors. However, comments by the US president on Tuesday when he warned of tariffs on pharmaceuticals of up to 250 per cent over coming years, naming Ireland as a target alongside China, will cause concern in Dublin. – Additional reporting Bloomberg, New York Times, Financial Times limited